P-118 Cetuximab Rechallenge in RAS, BRAF, EGFR-ECD Wild Type Metastatic Colorectal Cancer (mcrc) Patients Treated with Anti-Egfr Therapies in First Line: the CITRIC Study
Annals of Oncology(2022)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined